Development and Validation of a Model to Predict Tyrosine Kinase Inhibitor-Sensitive EGFR Mutations of Non-Small Cell Lung Cancer Based on Multi-Institutional Data

Thoracic Cancer - Australia
doi 10.1111/1759-7714.12881
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search